 | • レポートコード：GIR-107A12737 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、埋め込み型薬剤溶出デバイスのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。埋め込み型薬剤溶出デバイスの種類別市場規模（埋め込み型薬剤注入ポンプ、眼内薬剤溶出デバイス、避妊薬溶出デバイス、薬剤溶出ステント、その他）、用途別市場規模（糖尿病、避妊、HIV/AIDS予防、慢性疼痛管理、心臓血管、眼科、腫瘍、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・埋め込み型薬剤溶出デバイスの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Medtronic、Merck、Bayer AG、Johnson & Johnson、Abbott、Surmodics、Boston Scientific Corporation、Titan Pharmaceuticals, Inc.、BIOTRONIK、Allergan、Bausch & Lomb、REVA Medical、MicroPort Medical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：埋め込み型薬剤注入ポンプ、眼内薬剤溶出デバイス、避妊薬溶出デバイス、薬剤溶出ステント、その他 ・用途別分析2016年-2026年：糖尿病、避妊、HIV/AIDS予防、慢性疼痛管理、心臓血管、眼科、腫瘍、その他 ・埋め込み型薬剤溶出デバイスの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・埋め込み型薬剤溶出デバイスのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・埋め込み型薬剤溶出デバイスのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・埋め込み型薬剤溶出デバイスの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・埋め込み型薬剤溶出デバイスの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Implantable Drug-Eluting Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Implantable Drug-Eluting Devices size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Implantable Drug-Eluting Devices market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Implantable Drug-Eluting Devices market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Implantable Drug Infusion Pumps
Intraocular Drug-Eluting Devices
Contraceptive Drug-Eluting Devices
Drug-Eluting Stents
Others
Market segment by Application can be divided into
Diabetes
Contraception
HIV/AIDS Prevention
Chronic Pain Management
Cardiovascular
Ophthalmology
Oncology
Others
The key market players for global Implantable Drug-Eluting Devices market are listed below:
Pfizer
Medtronic
Merck
Bayer AG
Johnson & Johnson
Abbott
Surmodics
Boston Scientific Corporation
Titan Pharmaceuticals, Inc.
BIOTRONIK
Allergan
Bausch & Lomb
REVA Medical
MicroPort Medical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Implantable Drug-Eluting Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Implantable Drug-Eluting Devices, with price, sales, revenue and global market share of Implantable Drug-Eluting Devices in 2018 and 2019.
Chapter 3, the Implantable Drug-Eluting Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Implantable Drug-Eluting Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Implantable Drug-Eluting Devices market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Implantable Drug-Eluting Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Implantable Drug-Eluting Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Implantable Drug-Eluting Devices Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Implantable Drug Infusion Pumps
1.2.3 Intraocular Drug-Eluting Devices
1.2.4 Contraceptive Drug-Eluting Devices
1.2.5 Drug-Eluting Stents
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Implantable Drug-Eluting Devices Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Diabetes
1.3.3 Contraception
1.3.4 HIV/AIDS Prevention
1.3.5 Chronic Pain Management
1.3.6 Cardiovascular
1.3.7 Ophthalmology
1.3.8 Oncology
1.3.9 Others
1.4 Global Implantable Drug-Eluting Devices Market Size & Forecast
1.4.1 Global Implantable Drug-Eluting Devices Sales in Value (2016-2026))
1.4.2 Global Implantable Drug-Eluting Devices Sales in Volume (2016-2026)
1.4.3 Global Implantable Drug-Eluting Devices Price by Type (2016-2026) & (USD/Unit)
1.5 Global Implantable Drug-Eluting Devices Production Capacity Analysis
1.5.1 Global Implantable Drug-Eluting Devices Total Production Capacity (2016-2026)
1.5.2 Global Implantable Drug-Eluting Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Implantable Drug-Eluting Devices Market Drivers
1.6.2 Implantable Drug-Eluting Devices Market Restraints
1.6.3 Implantable Drug-Eluting Devices Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Implantable Drug-Eluting Devices Product and Services
2.1.4 Pfizer Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Implantable Drug-Eluting Devices Product and Services
2.2.4 Medtronic Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Implantable Drug-Eluting Devices Product and Services
2.3.4 Merck Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Bayer AG
2.4.1 Bayer AG Details
2.4.2 Bayer AG Major Business
2.4.3 Bayer AG Implantable Drug-Eluting Devices Product and Services
2.4.4 Bayer AG Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Implantable Drug-Eluting Devices Product and Services
2.5.4 Johnson & Johnson Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott Implantable Drug-Eluting Devices Product and Services
2.6.4 Abbott Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Surmodics
2.7.1 Surmodics Details
2.7.2 Surmodics Major Business
2.7.3 Surmodics Implantable Drug-Eluting Devices Product and Services
2.7.4 Surmodics Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Boston Scientific Corporation
2.8.1 Boston Scientific Corporation Details
2.8.2 Boston Scientific Corporation Major Business
2.8.3 Boston Scientific Corporation Implantable Drug-Eluting Devices Product and Services
2.8.4 Boston Scientific Corporation Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Titan Pharmaceuticals, Inc.
2.9.1 Titan Pharmaceuticals, Inc. Details
2.9.2 Titan Pharmaceuticals, Inc. Major Business
2.9.3 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product and Services
2.9.4 Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 BIOTRONIK
2.10.1 BIOTRONIK Details
2.10.2 BIOTRONIK Major Business
2.10.3 BIOTRONIK Implantable Drug-Eluting Devices Product and Services
2.10.4 BIOTRONIK Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Allergan
2.11.1 Allergan Details
2.11.2 Allergan Major Business
2.11.3 Allergan Implantable Drug-Eluting Devices Product and Services
2.11.4 Allergan Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Bausch & Lomb
2.12.1 Bausch & Lomb Details
2.12.2 Bausch & Lomb Major Business
2.12.3 Bausch & Lomb Implantable Drug-Eluting Devices Product and Services
2.12.4 Bausch & Lomb Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 REVA Medical
2.13.1 REVA Medical Details
2.13.2 REVA Medical Major Business
2.13.3 REVA Medical Implantable Drug-Eluting Devices Product and Services
2.13.4 REVA Medical Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 MicroPort Medical
2.14.1 MicroPort Medical Details
2.14.2 MicroPort Medical Major Business
2.14.3 MicroPort Medical Implantable Drug-Eluting Devices Product and Services
2.14.4 MicroPort Medical Implantable Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Implantable Drug-Eluting Devices Sales by Manufacturer
3.1 Global Implantable Drug-Eluting Devices Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Implantable Drug-Eluting Devices Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Implantable Drug-Eluting Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Implantable Drug-Eluting Devices Manufacturer Market Share
3.4.2 Top 6 Implantable Drug-Eluting Devices Manufacturer Market Share
3.5 Global Implantable Drug-Eluting Devices Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Implantable Drug-Eluting Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Implantable Drug-Eluting Devices Market Size by Region
4.1.1 Global Implantable Drug-Eluting Devices Sales in Volume by Region (2016-2026)
4.1.2 Global Implantable Drug-Eluting Devices Revenue by Region (2016-2026)
4.2 North America Implantable Drug-Eluting Devices Revenue (2016-2026)
4.3 Europe Implantable Drug-Eluting Devices Revenue (2016-2026)
4.4 Asia-Pacific Implantable Drug-Eluting Devices Revenue (2016-2026)
4.5 South America Implantable Drug-Eluting Devices Revenue (2016-2026)
4.6 Middle East and Africa Implantable Drug-Eluting Devices Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Implantable Drug-Eluting Devices Sales in Volume by Type (2016-2026)
5.2 Global Implantable Drug-Eluting Devices Revenue by Type (2016-2026)
5.3 Global Implantable Drug-Eluting Devices Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Implantable Drug-Eluting Devices Sales in Volume by Application (2016-2026)
6.2 Global Implantable Drug-Eluting Devices Revenue by Application (2016-2026)
6.3 Global Implantable Drug-Eluting Devices Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Implantable Drug-Eluting Devices Sales by Type (2016-2026)
7.2 North America Implantable Drug-Eluting Devices Sales by Application (2016-2026)
7.3 North America Implantable Drug-Eluting Devices Market Size by Country
7.3.1 North America Implantable Drug-Eluting Devices Sales in Volume by Country (2016-2026)
7.3.2 North America Implantable Drug-Eluting Devices Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Implantable Drug-Eluting Devices Sales by Type (2016-2026)
8.2 Europe Implantable Drug-Eluting Devices Sales by Application (2016-2026)
8.3 Europe Implantable Drug-Eluting Devices Market Size by Country
8.3.1 Europe Implantable Drug-Eluting Devices Sales in Volume by Country (2016-2026)
8.3.2 Europe Implantable Drug-Eluting Devices Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Implantable Drug-Eluting Devices Sales by Type (2016-2026)
9.2 Asia-Pacific Implantable Drug-Eluting Devices Sales by Application (2016-2026)
9.3 Asia-Pacific Implantable Drug-Eluting Devices Market Size by Region
9.3.1 Asia-Pacific Implantable Drug-Eluting Devices Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Implantable Drug-Eluting Devices Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Implantable Drug-Eluting Devices Sales by Type (2016-2026)
10.2 South America Implantable Drug-Eluting Devices Sales by Application (2016-2026)
10.3 South America Implantable Drug-Eluting Devices Market Size by Country
10.3.1 South America Implantable Drug-Eluting Devices Sales in Volume by Country (2016-2026)
10.3.2 South America Implantable Drug-Eluting Devices Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Implantable Drug-Eluting Devices Sales by Type (2016-2026)
11.2 Middle East & Africa Implantable Drug-Eluting Devices Sales by Application (2016-2026)
11.3 Middle East & Africa Implantable Drug-Eluting Devices Market Size by Country
11.3.1 Middle East & Africa Implantable Drug-Eluting Devices Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Implantable Drug-Eluting Devices Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Implantable Drug-Eluting Devices Typical Distributors
12.3 Implantable Drug-Eluting Devices Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Implantable Drug-Eluting Devices Revenue by Type, (USD Million), 2021-2026
Table 2. Global Implantable Drug-Eluting Devices Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Implantable Drug-Eluting Devices Product and Services
Table 6. Pfizer Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Medtronic Basic Information, Manufacturing Base and Competitors
Table 8. Medtronic Major Business
Table 9. Medtronic Implantable Drug-Eluting Devices Product and Services
Table 10. Medtronic Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Implantable Drug-Eluting Devices Product and Services
Table 14. Merck Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 16. Bayer AG Major Business
Table 17. Bayer AG Implantable Drug-Eluting Devices Product and Services
Table 18. Bayer AG Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Major Business
Table 21. Johnson & Johnson Implantable Drug-Eluting Devices Product and Services
Table 22. Johnson & Johnson Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Abbott Basic Information, Manufacturing Base and Competitors
Table 24. Abbott Major Business
Table 25. Abbott Implantable Drug-Eluting Devices Product and Services
Table 26. Abbott Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Surmodics Basic Information, Manufacturing Base and Competitors
Table 28. Surmodics Major Business
Table 29. Surmodics Implantable Drug-Eluting Devices Product and Services
Table 30. Surmodics Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 32. Boston Scientific Corporation Major Business
Table 33. Boston Scientific Corporation Implantable Drug-Eluting Devices Product and Services
Table 34. Boston Scientific Corporation Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Titan Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 36. Titan Pharmaceuticals, Inc. Major Business
Table 37. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Product and Services
Table 38. Titan Pharmaceuticals, Inc. Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. BIOTRONIK Basic Information, Manufacturing Base and Competitors
Table 40. BIOTRONIK Major Business
Table 41. BIOTRONIK Implantable Drug-Eluting Devices Product and Services
Table 42. BIOTRONIK Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Allergan Basic Information, Manufacturing Base and Competitors
Table 44. Allergan Major Business
Table 45. Allergan Implantable Drug-Eluting Devices Product and Services
Table 46. Allergan Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Bausch & Lomb Basic Information, Manufacturing Base and Competitors
Table 48. Bausch & Lomb Major Business
Table 49. Bausch & Lomb Implantable Drug-Eluting Devices Product and Services
Table 50. Bausch & Lomb Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. REVA Medical Basic Information, Manufacturing Base and Competitors
Table 52. REVA Medical Major Business
Table 53. REVA Medical Implantable Drug-Eluting Devices Product and Services
Table 54. REVA Medical Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. MicroPort Medical Basic Information, Manufacturing Base and Competitors
Table 56. MicroPort Medical Major Business
Table 57. MicroPort Medical Implantable Drug-Eluting Devices Product and Services
Table 58. MicroPort Medical Implantable Drug-Eluting Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Global Implantable Drug-Eluting Devices Sales by Manufacturer (2019-2021e) & (K Units)
Table 60. Global Implantable Drug-Eluting Devices Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 61. Market Position of Manufacturers in Implantable Drug-Eluting Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 62. Global Implantable Drug-Eluting Devices Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Implantable Drug-Eluting Devices Production Site of Key Manufacturer
Table 64. Implantable Drug-Eluting Devices New Entrant and Capacity Expansion Plans
Table 65. Implantable Drug-Eluting Devices Mergers & Acquisitions in the Past Five Years
Table 66. Global Implantable Drug-Eluting Devices Sales by Region (2016-2021e) & (K Units)
Table 67. Global Implantable Drug-Eluting Devices Sales by Region (2021-2026) & (K Units)
Table 68. Global Implantable Drug-Eluting Devices Revenue by Region (2016-2021e) & (USD Million)
Table 69. Global Implantable Drug-Eluting Devices Revenue by Region (2021-2026) & (USD Million)
Table 70. Global Implantable Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units)
Table 71. Global Implantable Drug-Eluting Devices Sales by Type (2021-2026) & (K Units)
Table 72. Global Implantable Drug-Eluting Devices Revenue by Type (2016-2021e) & (USD Million)
Table 73. Global Implantable Drug-Eluting Devices Revenue by Type (2021-2026) & (USD Million)
Table 74. Global Implantable Drug-Eluting Devices Price by Type (2016-2021e) & (USD/Unit)
Table 75. Global Implantable Drug-Eluting Devices Price by Type (2021-2026) & (USD/Unit)
Table 76. Global Implantable Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units)
Table 77. Global Implantable Drug-Eluting Devices Sales by Application (2021-2026) & (K Units)
Table 78. Global Implantable Drug-Eluting Devices Revenue by Application (2016-2021e) & (USD Million)
Table 79. Global Implantable Drug-Eluting Devices Revenue by Application (2021-2026) & (USD Million)
Table 80. Global Implantable Drug-Eluting Devices Price by Application (2016-2021e) & (USD/Unit)
Table 81. Global Implantable Drug-Eluting Devices Price by Application (2021-2026) & (USD/Unit)
Table 82. North America Implantable Drug-Eluting Devices Sales by Country (2016-2021e) & (K Units)
Table 83. North America Implantable Drug-Eluting Devices Sales by Country (2021-2026) & (K Units)
Table 84. North America Implantable Drug-Eluting Devices Revenue by Country (2016-2021e) & (USD Million)
Table 85. North America Implantable Drug-Eluting Devices Revenue by Country (2021-2026) & (USD Million)
Table 86. North America Implantable Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units)
Table 87. North America Implantable Drug-Eluting Devices Sales by Type (2021-2026) & (K Units)
Table 88. North America Implantable Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units)
Table 89. North America Implantable Drug-Eluting Devices Sales by Application (2021-2026) & (K Units)
Table 90. Europe Implantable Drug-Eluting Devices Sales by Country (2016-2021e) & (K Units)
Table 91. Europe Implantable Drug-Eluting Devices Sales by Country (2021-2026) & (K Units)
Table 92. Europe Implantable Drug-Eluting Devices Revenue by Country (2016-2021e) & (USD Million)
Table 93. Europe Implantable Drug-Eluting Devices Revenue by Country (2021-2026) & (USD Million)
Table 94. Europe Implantable Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units)
Table 95. Europe Implantable Drug-Eluting Devices Sales by Type (2021-2026) & (K Units)
Table 96. Europe Implantable Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units)
Table 97. Europe Implantable Drug-Eluting Devices Sales by Application (2021-2026) & (K Units)
Table 98. Asia-Pacific Implantable Drug-Eluting Devices Sales by Region (2016-2021e) & (K Units)
Table 99. Asia-Pacific Implantable Drug-Eluting Devices Sales by Region (2021-2026) & (K Units)
Table 100. Asia-Pacific Implantable Drug-Eluting Devices Revenue by Region (2016-2021e) & (USD Million)
Table 101. Asia-Pacific Implantable Drug-Eluting Devices Revenue by Region (2021-2026) & (USD Million)
Table 102. Asia-Pacific Implantable Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units)
Table 103. Asia-Pacific Implantable Drug-Eluting Devices Sales by Type (2021-2026) & (K Units)
Table 104. Asia-Pacific Implantable Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units)
Table 105. Asia-Pacific Implantable Drug-Eluting Devices Sales by Application (2021-2026) & (K Units)
Table 106. South America Implantable Drug-Eluting Devices Sales by Country (2016-2021e) & (K Units)
Table 107. South America Implantable Drug-Eluting Devices Sales by Country (2021-2026) & (K Units)
Table 108. South America Implantable Drug-Eluting Devices Revenue by Country (2016-2021e) & (USD Million)
Table 109. South America Implantable Drug-Eluting Devices Revenue by Country (2021-2026) & (USD Million)
Table 110. South America Implantable Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units)
Table 111. South America Implantable Drug-Eluting Devices Sales by Type (2021-2026) & (K Units)
Table 112. South America Implantable Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units)
Table 113. South America Implantable Drug-Eluting Devices Sales by Application (2021-2026) & (K Units)
Table 114. Middle East & Africa Implantable Drug-Eluting Devices Sales by Country (2016-2021e) & (K Units)
Table 115. Middle East & Africa Implantable Drug-Eluting Devices Sales by Country (2021-2026) & (K Units)
Table 116. Middle East & Africa Implantable Drug-Eluting Devices Revenue by Country (2016-2021e) & (USD Million)
Table 117. Middle East & Africa Implantable Drug-Eluting Devices Revenue by Country (2021-2026) & (USD Million)
Table 118. Middle East & Africa Implantable Drug-Eluting Devices Sales by Type (2016-2021e) & (K Units)
Table 119. Middle East & Africa Implantable Drug-Eluting Devices Sales by Type (2021-2026) & (K Units)
Table 120. Middle East & Africa Implantable Drug-Eluting Devices Sales by Application (2016-2021e) & (K Units)
Table 121. Middle East & Africa Implantable Drug-Eluting Devices Sales by Application (2021-2026) & (K Units)
Table 122. Direct Channel Pros & Cons
Table 123. Indirect Channel Pros & Cons
Table 124. Implantable Drug-Eluting Devices Typical Distributors
Table 125. Implantable Drug-Eluting Devices Typical Customers
List of Figures
Figure 1. Implantable Drug-Eluting Devices Picture
Figure 2. Global Implantable Drug-Eluting Devices Sales Market Share by Type in 2020
Figure 3. Implantable Drug Infusion Pumps
Figure 4. Intraocular Drug-Eluting Devices
Figure 5. Contraceptive Drug-Eluting Devices
Figure 6. Drug-Eluting Stents
Figure 7. Others
Figure 8. Global Implantable Drug-Eluting Devices Sales Market Share by Application in 2020
Figure 9. Diabetes
Figure 10. Contraception
Figure 11. HIV/AIDS Prevention
Figure 12. Chronic Pain Management
Figure 13. Cardiovascular
Figure 14. Ophthalmology
Figure 15. Oncology
Figure 16. Others
Figure 17. Global Implantable Drug-Eluting Devices Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 18. Global Implantable Drug-Eluting Devices Market Size and Forecast (2016-2026) & (USD Million)
Figure 19. Global Implantable Drug-Eluting Devices Sales (2016-2026) & (K Units)
Figure 20. Global Implantable Drug-Eluting Devices Price by Type (2016-2026) & (USD/Unit)
Figure 21. Global Implantable Drug-Eluting Devices Production Capacity (2016-2026) & (K Units)
Figure 22. Global Implantable Drug-Eluting Devices Production Capacity by Geographic Region: 2020 VS 2021
Figure 23. Implantable Drug-Eluting Devices Market Drivers
Figure 24. Implantable Drug-Eluting Devices Market Restraints
Figure 25. Implantable Drug-Eluting Devices Market Trends
Figure 26. Global Implantable Drug-Eluting Devices Sales Market Share by Manufacturer in 2020
Figure 27. Global Implantable Drug-Eluting Devices Revenue Market Share by Manufacturer in 2020
Figure 28. Implantable Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 29. Top 3 Implantable Drug-Eluting Devices Manufacturer (Revenue) Market Share in 2020
Figure 30. Top 6 Implantable Drug-Eluting Devices Manufacturer (Revenue) Market Share in 2020
Figure 31. Global Implantable Drug-Eluting Devices Sales Market Share by Region (2016-2026)
Figure 32. Global Implantable Drug-Eluting Devices Revenue Market Share by Region (2016-2026)
Figure 33. North America Implantable Drug-Eluting Devices Revenue (2016-2026) & (USD Million)
Figure 34. Europe Implantable Drug-Eluting Devices Revenue (2016-2026) & (USD Million)
Figure 35. Asia-Pacific Implantable Drug-Eluting Devices Revenue (2016-2026) & (USD Million)
Figure 36. South America Implantable Drug-Eluting Devices Revenue (2016-2026) & (USD Million)
Figure 37. Middle East & Africa Implantable Drug-Eluting Devices Revenue (2016-2026) & (USD Million)
Figure 38. Global Implantable Drug-Eluting Devices Sales Market Share by Type (2016-2026)
Figure 39. Global Implantable Drug-Eluting Devices Revenue Market Share by Type (2016-2026)
Figure 40. Global Implantable Drug-Eluting Devices Price by Type (2016-2026) & (USD/Unit)
Figure 41. Global Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2026)
Figure 42. Global Implantable Drug-Eluting Devices Revenue Market Share by Application (2016-2026)
Figure 43. Global Implantable Drug-Eluting Devices Price by Application (2016-2026) & (USD/Unit)
Figure 44. North America Implantable Drug-Eluting Devices Sales Market Share by Type (2016-2026)
Figure 45. North America Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2026)
Figure 46. North America Implantable Drug-Eluting Devices Sales Market Share by Country (2016-2026)
Figure 47. North America Implantable Drug-Eluting Devices Revenue Market Share by Country (2016-2026)
Figure 48. United States Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Implantable Drug-Eluting Devices Sales Market Share by Type (2016-2026)
Figure 52. Europe Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2026)
Figure 53. Europe Implantable Drug-Eluting Devices Sales Market Share by Country (2016-2026)
Figure 54. Europe Implantable Drug-Eluting Devices Revenue Market Share by Country (2016-2026)
Figure 55. Germany Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Implantable Drug-Eluting Devices Sales Market Share by Region (2016-2026)
Figure 61. Asia-Pacific Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Implantable Drug-Eluting Devices Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Implantable Drug-Eluting Devices Revenue Market Share by Region (2016-2026)
Figure 64. China Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Korea Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America Implantable Drug-Eluting Devices Sales Market Share by Type (2016-2026)
Figure 71. South America Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2026)
Figure 72. South America Implantable Drug-Eluting Devices Sales Market Share by Country (2016-2026)
Figure 73. South America Implantable Drug-Eluting Devices Revenue Market Share by Country (2016-2026)
Figure 74. Brazil Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Argentina Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Middle East & Africa Implantable Drug-Eluting Devices Sales Market Share by Type (2016-2026)
Figure 77. Middle East & Africa Implantable Drug-Eluting Devices Sales Market Share by Application (2016-2026)
Figure 78. Middle East & Africa Implantable Drug-Eluting Devices Sales Market Share by Country (2016-2026)
Figure 79. Middle East & Africa Implantable Drug-Eluting Devices Revenue Market Share by Country (2016-2026)
Figure 80. Turkey Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Egypt Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Saudi Arabia Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. South Africa Implantable Drug-Eluting Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Figure 85. Methodology
Figure 86. Research Process and Data Source
世界の末梢性インターベンション薬剤溶出装置市場 2021：企業別、地域別、種類・用途別 The Peripheral Intervention Drug-Eluting Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…- 世界の薬剤溶出性バルーン（DEB）市場 2021：企業別、地域別、種類・用途別 The Drug Eluting Balloons (DEB) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界の末梢動脈疾患用薬剤溶出性バルーン市場 2021：企業別、地域別、種類・用途別 The Drug Eluting Balloon for Peripheral Artery Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …
- 世界の薬剤溶出性バルーン（DEB）市場 2021：企業別、地域別、種類・用途別 The Drug Eluting Balloons（DEB） market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界のPTCA冠状動脈薬剤溶出バルーン市場 2021：企業別、地域別、種類・用途別 The PTCA Coronary Drug Eluting Balloons market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…